Cannabis Diagnostics TUMI Genomics offers rapid on site pathogen detection and preventative care tailored for legal cannabis, presenting a ready to sell solution for cultivation facilities seeking real time disease surveillance to protect yields and quality. Target audiences include large multi site growers, boutique cultivators, and extraction facilities that require fast, actionable results.

On-site Platform The company’s proprietary rapid on site platform combined with specialized in lab services enables flexible engagement models, opening sales opportunities for maintenance contracts, recurring diagnostics subscriptions, and scalable pathogen prevention programs across grow operations of varying sizes.

Strategic Partnerships The September 2025 collaboration with StateHouse Holdings to study HLVd infection dynamics demonstrates readiness for joint pilots and research partnerships, which can be leveraged to land co development deals, sponsored studies, and access to investor networks in the cannabis biotech space.

Regulatory Focus Operating in the regulated cannabis sector, TUMI Genomics can position as a QA and compliance ally for regulatory reporting, audits, and quality control programs, creating opportunities with cultivation facilities, testing labs, and cannabis operators aiming to demonstrate robust pathogen prevention.

Growth & Expansion With current revenue in the mid tens of millions and a Colorado base, there is potential to scale across additional legalized markets and related horticultural segments, offering phased solutions for multi site operators and partnerships with regional distributors or CROs to accelerate adoption.